CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1 enrolled
Drug / intervention
Neurostar Transcranial Magnetic Stimulation Therapy Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02236767
NCT02236767N/ACompleted
CompareCT.gov

Transcranial Magnetic Stimulation Treatment of Hoarding Disorder

Hartford Hospital·interventional·Posted Sep 11, 2014·Updated Oct 6, 2016

In Brief

A clinical study evaluating Neurostar Transcranial Magnetic Stimulation Therapy System for Hoarding. Completed, enrolled 1 participant across 1 site.

Detailed Summary

This is multiple baseline study including up to three participants with a primary diagnosis of hoarding disorder. All patients will receive unblinded repetitive transcranial magnetic stimulation study intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHoarding
CountriesUnited States
CollaboratorsNeuronetics

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 11, 2014
Enrollment StartJul 1, 2014
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.8 years ago

Interventions

Neurostar Transcranial Magnetic Stimulation Therapy Systemdevice

Treatment will entail daily (5 days/week) sessions of repetitive transcranial magnetic stimulation for 6 weeks employing right-sided, low frequency stimulation (1 Hz, 900 pulses/session for 30 sessions, 27,000 total pulses, intensity at 90% of the passive motor threshold) to the dorsolateral prefrontal cortex (DLPFC).